SynBiotic SE Market Cap ($1.35 Million)
Market Cap & Net Worth: SynBiotic SE (SBX)
SynBiotic SE market cap. SynBiotic SE (F:SBX) has a market capitalization of $1.35 Million (€1.16 Million) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #30436 globally and #2648 in its home market, demonstrating a -0.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SynBiotic SE's stock price €0.15 by its total outstanding shares 7656954 (7.66 Million). Also see SynBiotic SE cash conversion from operations for how efficiently the company converts equity into cash flow.
SynBiotic SE Market Cap History (2021–2026)
SynBiotic SE market cap history from 2021 to 2026. Data shows change from $264.97 Million to $1.35 Million (-56.71% CAGR). Check SBX stock price and chart for real-time trading data and today's change.
SynBiotic SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SynBiotic SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SynBiotic SE equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.55x
SynBiotic SE's market cap is 2.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $264.97 Million | $9.06 Million | -$12.72 Million | 29.23x | N/A |
| 2022 | $94.71 Million | $8.17 Million | -$24.36 Million | 11.60x | N/A |
| 2023 | $27.75 Million | $3.86 Million | -$10.63 Million | 7.19x | N/A |
| 2024 | $36.43 Million | $14.31 Million | -$9.72 Million | 2.55x | N/A |
Competitor Companies of SBX by Market Capitalization
Companies near SynBiotic SE in the global market cap rankings as of November 3, 2026. Also see SBX asset base for a full breakdown of the balance sheet.
Key companies related to SynBiotic SE by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of SynBiotic SE (2021–2026)
Market capitalization of SynBiotic SE from 2021 to today. Between 2021 and today, SynBiotic SE's market cap moved from $264.97 Million to $ 1.35 Million, with a yearly change of -56.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.35 Million | -94.96% |
| 2025 | €26.81 Million | -26.41% |
| 2024 | €36.43 Million | +31.29% |
| 2023 | €27.75 Million | -70.70% |
| 2022 | €94.71 Million | -64.26% |
| 2021 | €264.97 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of SynBiotic SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.35 Million USD |
| MoneyControl | $1.35 Million USD |
| MarketWatch | $1.35 Million USD |
| marketcap.company | $1.35 Million USD |
| Reuters | $1.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SynBiotic SE
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. T… Read more